INDIANA — Federal health regulators and major retailers are urging consumers to check their medicine cabinets following a ...

Drugmaker Sanofi announced on Friday a voluntary recall of the heartburn drug Zantac from all stores in the United States and Canada amid investigations into the presence of a carcinogen discovered in ...

A new nationwide recall has been issued for a generic version of the heartburn and ulcer drug Zantac due to the potential presence of an impurity that could cause cancer. It's the fourth recall for ...

Another recall has been issued for a generic version of a popular heartburn drug best known as Zantac due to the presence of a potentially cancer-causing impurity. It's the latest in several such ...

A drugmaker has announced they are recalling some generic versions of the popular heartburn medication Zantac sold at Walgreens, Walmart, and Rite-Aid over concerns about a potentially dangerous ...

WASHINGTON — The Food and Drug Administration on Wednesday said it is asking all companies to stop selling all versions of the heartburn drug Zantac, due to the presence of an impurity that could ...

Update 8:55 a.m. EST, Nov 13: The Food and Drug Administration is telling patients and health professionals about two more voluntary recalls of ranitidine. Amneal Pharmaceuticals LLC has recalled ...

The series of recalls of ranitidine (also known as Zantac) and nizatidine products grew longer with three US Food and Drug Administration (FDA) announcements on Tuesday and Wednesday. The 150 mg and ...

As the US Food and Drug Administration (FDA) continues to test ranitidine products, including the popular heartburn medicine Zantac, from multiple manufacturers for the carcinogen ...

WASHINGTON — The U.S. Food and Drug Administration has approved a reformulated version of ranitidine, which was sold widely under the brand name Zantac, allowing the acid-reducing drug to return to ...